Neutrophils Kill Antibody-Opsonized Cancer Cells by Trogoptosis

Cell Rep. 2018 Jun 26;23(13):3946-3959.e6. doi: 10.1016/j.celrep.2018.05.082.

Abstract

Destruction of cancer cells by therapeutic antibodies occurs, at least in part, through antibody-dependent cellular cytotoxicity (ADCC), and this can be mediated by various Fc-receptor-expressing immune cells, including neutrophils. However, the mechanism(s) by which neutrophils kill antibody-opsonized cancer cells has not been established. Here, we demonstrate that neutrophils can exert a mode of destruction of cancer cells, which involves antibody-mediated trogocytosis by neutrophils. Intimately associated with this is an active mechanical disruption of the cancer cell plasma membrane, leading to a lytic (i.e., necrotic) type of cancer cell death. Furthermore, this mode of destruction of antibody-opsonized cancer cells by neutrophils is potentiated by CD47-SIRPα checkpoint blockade. Collectively, these findings show that neutrophil ADCC toward cancer cells occurs by a mechanism of cytotoxicity called trogoptosis, which can be further improved by targeting CD47-SIRPα interactions.

Keywords: CD47-SIRPα interaction; antibody-dependent cellular cytotoxicity; neutrophils; trogocytosis; trogoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Antibody-Dependent Cell Cytotoxicity*
  • CD11b Antigen / metabolism
  • CD18 Antigens / metabolism
  • CD47 Antigen / metabolism
  • Cell Line, Tumor
  • Female
  • Humans
  • Male
  • Melanoma, Experimental / metabolism
  • Melanoma, Experimental / pathology
  • Mice
  • Mice, Inbred C57BL
  • Neoplasms / drug therapy
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neutrophils / immunology*
  • Receptors, IgG / metabolism
  • Receptors, Immunologic / genetics
  • Receptors, Immunologic / metabolism
  • Transplantation, Homologous

Substances

  • Antibodies, Monoclonal
  • CD11b Antigen
  • CD18 Antigens
  • CD47 Antigen
  • Receptors, IgG
  • Receptors, Immunologic